Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 20

1.

Ultrasound and optic neuritis.

Cornetta P, Marotta G, De Bernardo M, Vitiello L, Rosa N.

Am J Emerg Med. 2019 Feb 4. pii: S0735-6757(19)30079-8. doi: 10.1016/j.ajem.2019.02.001. [Epub ahead of print] No abstract available.

PMID:
30744912
2.

Fingolimod reduces circulating tight-junction protein levels and in vitro peripheral blood mononuclear cells migration in multiple sclerosis patients.

Annunziata P, Cioni C, Masi G, Tassi M, Marotta G, Severi S.

Sci Rep. 2018 Oct 18;8(1):15371. doi: 10.1038/s41598-018-33672-9.

3.

Corneal biomechanical parameters in pellucid marginal degeneration.

De Bernardo M, Cornetta P, Marotta G, Rosa N.

J Curr Ophthalmol. 2018 Jun 23;30(3):280. doi: 10.1016/j.joco.2018.06.002. eCollection 2018 Sep. No abstract available.

4.

A Prospective Longitudinal Study to Investigate Corneal Hysteresis as a Risk Factor for Predicting Development of Glaucoma.

De Bernardo M, Cornetta P, Marotta G, Rosa N.

Am J Ophthalmol. 2018 Nov;195:243. doi: 10.1016/j.ajo.2018.04.030. Epub 2018 Aug 24. No abstract available.

PMID:
30149890
5.

The role of production process and information on quality expectations and perceptions of sparkling wines.

Vecchio R, Lisanti MT, Caracciolo F, Cembalo L, Gambuti A, Moio L, Siani T, Marotta G, Nazzaro C, Piombino P.

J Sci Food Agric. 2019 Jan 15;99(1):124-135. doi: 10.1002/jsfa.9153. Epub 2018 Jul 20.

PMID:
29808544
6.

Use of Leukocyte Platelet (L-PRF) Rich Fibrin in Diabetic Foot Ulcer with Osteomyelitis (Three Clinical Cases Report).

Crisci A, Marotta G, Licito A, Serra E, Benincasa G, Crisci M.

Diseases. 2018 Apr 24;6(2). pii: E30. doi: 10.3390/diseases6020030.

7.

Sonography of the Optic Nerve Sheath Diameter.

De Bernardo M, Marotta G, Rosa N.

J Ultrasound Med. 2018 Jul;37(7):1845. doi: 10.1002/jum.14486. Epub 2017 Nov 17. No abstract available.

PMID:
29148071
8.

Busulfan plus cyclophosphamide versus busulfan plus fludarabine as a preparative regimen for allogeneic haemopoietic stem-cell transplantation in patients with acute myeloid leukaemia: an open-label, multicentre, randomised, phase 3 trial.

Rambaldi A, Grassi A, Masciulli A, Boschini C, Micò MC, Busca A, Bruno B, Cavattoni I, Santarone S, Raimondi R, Montanari M, Milone G, Chiusolo P, Pastore D, Guidi S, Patriarca F, Risitano AM, Saporiti G, Pini M, Terruzzi E, Arcese W, Marotta G, Carella AM, Nagler A, Russo D, Corradini P, Alessandrino EP, Torelli GF, Scimè R, Mordini N, Oldani E, Marfisi RM, Bacigalupo A, Bosi A.

Lancet Oncol. 2015 Nov;16(15):1525-1536. doi: 10.1016/S1470-2045(15)00200-4. Epub 2015 Sep 28.

9.

Allogeneic haematopoietic stem cell transplantation for mitochondrial neurogastrointestinal encephalomyopathy.

Halter JP, Michael W, Schüpbach M, Mandel H, Casali C, Orchard K, Collin M, Valcarcel D, Rovelli A, Filosto M, Dotti MT, Marotta G, Pintos G, Barba P, Accarino A, Ferra C, Illa I, Beguin Y, Bakker JA, Boelens JJ, de Coo IF, Fay K, Sue CM, Nachbaur D, Zoller H, Sobreira C, Pinto Simoes B, Hammans SR, Savage D, Martí R, Chinnery PF, Elhasid R, Gratwohl A, Hirano M.

Brain. 2015 Oct;138(Pt 10):2847-58. doi: 10.1093/brain/awv226. Epub 2015 Aug 10.

10.

Product reformulation in the food system to improve food safety. Evaluation of policy interventions.

Marotta G, Simeone M, Nazzaro C.

Appetite. 2014 Mar;74:107-15. doi: 10.1016/j.appet.2013.12.003. Epub 2013 Dec 16.

PMID:
24355908
11.

Pluripotency regulators in human mesenchymal stem cells: expression of NANOG but not of OCT-4 and SOX-2.

Pierantozzi E, Gava B, Manini I, Roviello F, Marotta G, Chiavarelli M, Sorrentino V.

Stem Cells Dev. 2011 May;20(5):915-23. doi: 10.1089/scd.2010.0353. Epub 2010 Oct 29.

PMID:
20879854
12.

Is complement alternative pathway disregulation involved in veno-occlusive disease of the liver?

Bucalossi A, Toraldo F, Tozzi M, Lenoci M, Castagnini C, Artuso R, Renieri A, Marotta G.

Biol Blood Marrow Transplant. 2010 Dec;16(12):1749-50. doi: 10.1016/j.bbmt.2010.09.002. Epub 2010 Sep 19. No abstract available.

13.

Treatment of keratoconus by topography-guided customized photorefractive keratectomy: two-year follow-up study.

Cennamo G, Intravaja A, Boccuzzi D, Marotta G, Cennamo G.

J Refract Surg. 2008 Feb;24(2):145-9. doi: 10.3928/1081597X-20080201-04.

PMID:
18297938
14.

Unrelated donor haematopoietic cell transplantation after non-myeloablative conditioning for patients with high-risk multiple myeloma.

Bruno B, Sorasio R, Patriarca F, Montefusco V, Guidi S, Busca A, Scimé R, Console G, Milone G, Marotta G, Dominietto A, Giaccone L, Rotta M, Falda M, Bacigalupo A, Bosi A, Corradini P, Fanin R, Pollichieni S, Boccadoro M; Gruppo Italiano Trapianto Midollo Osseo.

Eur J Haematol. 2007 Apr;78(4):330-7. Epub 2007 Feb 27.

PMID:
17331132
15.

Role of interferon-alpha administration after 2-deoxycoformycin in the treatment of hairy cell leukemia patients.

Marotta G, Frassoldati A, Zinzani P, Annino L, Brugiatelli M, Ambrosetti A, Lenoci M, Federico M, Foa R, Lauria F; Italian Cooperative group for HCL (ICGHCL).

Eur J Haematol. 2006 Aug;77(2):109-13.

PMID:
16856905
16.

Complete resolution of hepatic aspergillosis after non-myeloablative hematopoietic stem cell transplantation in a patient with acute myeloid leukemia.

Marotta G, Tozzi M, Sammassimo S, Defina M, Raspadori D, Gozzetti A, Lauria F.

Hematology. 2005 Oct;10(5):383-6.

PMID:
16273726
17.

Trisomy 12 and t(14;22)(q32;q11) in a patient with B-cell chronic lymphocytic leukemia.

Gozzetti A, Marotta G, Lenoci M, Crupi R, Tozzuoli D, Calabrese S, Forconi F, Fabbri A, Lauria F.

Hematology. 2004 Oct-Dec;9(5-6):405-7.

PMID:
15763981
18.

Low-dose oral fludarabine plus cyclophosphamide in elderly patients with chronic lymphoproliferative disorders.

Fabbri A, Lenoci M, Gozzetti A, Marotta G, Raspadori D, Forconi F, Lauria F.

Hematol J. 2004;5(6):472-4.

PMID:
15570287
19.

New formula to calculate corneal power after refractive surgery.

Ferrara G, Cennamo G, Marotta G, Loffredo E.

J Refract Surg. 2004 Sep-Oct;20(5):465-71.

PMID:
15523958
20.

Efficacy of rituximab in the treatment of refractory chronic lymphocytic leukemia patient with bone marrow aplasia.

Marotta G, Lenoci M, Fabbri A, Tozzi M, Lauria F.

Hematol J. 2002;3(6):299-301.

PMID:
12522452

Supplemental Content

Loading ...
Support Center